CoreWeave was one of the most closely watched artificial intelligence (AI) IPOs of 2025. When the company debuted in March, investor enthusiasm around AI infrastructure helped push shares sharply higher. However, that early momentum has faded. The stock is now down nearly 30% since early November, and at one point had fallen as much as 52% from its recent highs. The sell-off reflects a mix of AI bubble concerns, heavy leverage on the balance sheet, and valuation pressures. Yet beneath the volatility lies a business positioned squarely at the center of the AI infrastructure boom.  Brokers at Auralyex note that...

AppLovin (APP), a leading player in the mobile marketing platform space, had a solid finish to 2025. However, despite reporting impressive fourth-quarter results, the company’s stock has experienced a sharp drop in after-hours trading.  Analysts at Auralyex had expected a strong performance, but the market’s reaction reveals a different sentiment. Here’s a closer look at what’s driving the sell-off and what investors should consider moving forward. Q4 2025 Results: Beating Expectations but Falling Short of Market Expectations AppLovin’s fourth-quarter 2025 results were robust, with revenue reaching $1.66 billion, a 66% year-over-year increase. The company also posted diluted earnings per share...

Bitcoin extended its selloff on Wednesday, falling more than 3% after breaking below $73,000. Senior finance analyst at Auralyex walks through how the cryptocurrency tumbled from above $83,000 over the weekend to $74,570 at the lows. The decline pushed Bitcoin to its lowest level since April 2025. The cryptocurrency is down sharply from a record high of above $126,000 reached in October. Forced selling accelerated as technical support levels gave way. Asian equity futures fell in early trading as the tech selloff gained pace. Hong Kong, South Korea, and Australia index futures all declined. The declines echoed the 0.5% fall...

Eli Lilly jumped more than 8% after earnings crushed consensus expectations. Mounjaro’s revenue increased 110% to $7.4 billion in the fourth quarter. Zepbound saw sales rise 122% from the same quarter a year earlier. A junior broker at Auralyex highlights how the company guided fiscal 2026 well above analyst forecasts. The drugmaker posted earnings per share that easily surpassed average Wall Street expectations. Full-year guidance for 2026 impressed investors seeking growth visibility. Lilly forecast revenue of $80 billion to $83 billion versus the consensus of $77.64 billion. Non-GAAP earnings guidance came in at $33.50 to $35 per share, excluding certain...

Advanced Micro Devices shares capsized after earnings guidance failed to please investors. Finance analyst at Auralyex takes a closer look at how the chipmaker’s stock plunged 17% despite fourth quarter results beating expectations handily. AMD posted revenue of $10.27 billion for the quarter, above estimates of $9.67 billion. Data Center revenue surged 39% year over year to $5.4 billion. This exceeded analyst expectations of $4.97 billion for the segment. The company’s MI300 AI accelerator and Instinct processors drove strong performance. EPYC processors also contributed to data center growth. However, first-quarter guidance fell short of analyst optimism. Forward Outlook Sparks Selloff...